Guilan Zhou; Ying Li; Hairui Wang; Yuanyuan Wang; Yuan Gao; Juan Xu; Fengshuang Wang; Tao Peng; Maojun Zhang; Zhujun Shao; Guilan Zhou; Ying Li; Hairui Wang; Yuanyuan Wang; Yuan Gao; Juan Xu; Fengshuang Wang; Tao Peng; Maojun Zhang; Zhujun Shao

doi:10.46234/ccdcw2024.085

[1]

Mattoo S, Cherry JD. Molecular pathogenesis, epidemiology, and clinical manifestations of respiratory infections due to Bordetella pertussis and other Bordetella subspecies. Clin Microbiol Rev 2005;18(2):326 − 82. https://doi.org/10.1128/CMR.18.2.326-382.2005.

[2]

Long Z, Wei C, Zhan ZQ, Ma X, Li XL, Li YQ, et al. Quantitative determination of bioactive proteins in diphtheria tetanus acellular pertussis (DTaP) vaccine by liquid chromatography tandem mass spectrometry. J Pharm Biomed Anal 2019;169:30 − 40. https://doi.org/10.1016/j.jpba.2019.02.029.

[3]

Weigand MR, Pawloski LC, Peng YH, Ju H, Burroughs M, Cassiday PK, et al. Screening and genomic characterization of filamentous hemagglutinin-deficient Bordetella pertussis. Infect Immun 2018;86(4):e00869 − 17. https://doi.org/10.1128/IAI.00869-17.

[4]

Pawloski LC, Queenan AM, Cassiday PK, Lynch AS, Harrison MJ, Shang W, et al. Prevalence and molecular characterization of pertactin-deficient Bordetella pertussis in the United States. Clin Vaccine Immunol 2014;21(2):119 − 25. https://doi.org/10.1128/CVI.00717-13.

[5]

Fu P, Wang CQ, Tian H, Kang ZH, Zeng M. Bordetella pertussis infection in infants and young children in Shanghai, China, 2016-2017: clinical features, genotype variations of antigenic genes and macrolides resistance. Pediatr Infect Dis J 2019;38(4):370 − 6. https://doi.org/10.1097/INF.0000000000002160.

[6]

Li LJ, Deng JK, Ma X, Zhou K, Meng QH, Yuan L, et al. High prevalence of macrolide-resistant Bordetella pertussis and ptxP1 genotype, Mainland China, 2014-2016. Emerg Infect Dis 2019;25(12):2205 − 14. https://doi.org/10.3201/eid2512.181836.

[7]

Cai JH, Chen ML, Liu QY, Luo JY, Yuan LY, Chen YX, et al. Domination of an emerging erythromycin-resistant ptxP3 Bordetella pertussis clone in Shanghai, China. Int J Antimicrob Agents 2023;62(1):106835. https://doi.org/10.1016/j.ijantimicag.2023.106835.

[8]

Xu Z, Wang ZG, Luan Y, Li YR, Liu XG, Peng XK, et al. Genomic epidemiology of erythromycin-resistant Bordetella pertussis in China. Emerg Microbes Infect 2019;8(1):461 − 70. https://doi.org/10.1080/22221751.2019.1587315.

[9]

Xu Z, Hu DL, Luu LDW, Octavia S, Keil AD, Sintchenko V, et al. Genomic dissection of the microevolution of Australian epidemic Bordetella pertussis. Emerg Microbes Infect 2022;11(1):1460 − 73. https://doi.org/10.1080/22221751.2022.2077129.

[10]

Mooi FR, van Loo IHM, van Gent M, He QS, Bart MJ, Heuvelman KJ, et al. Bordetella pertussis strains with increased toxin production associated with pertussis resurgence. Emerg Infect Dis 2009;15(8):1206 − 13. https://doi.org/10.3201/eid1508.081511.